Evidence map›Paper›PMID 42433361›Full record

SynthesisFrontiers in immunology2026

Diagnostic accuracy and association with lymph node metastasis of the systemic immune-inflammation index in thyroid cancer: a systematic review and meta-analysis.

Ruxandra Stefania Dragota, Michael Schenker, Ana-Maria Ciurea, Adina Turcu-Stiolica, Mihaela Popescu, Andreea Stanculescu, Bogdan Silviu Ungureanu, Tudorel Ciurea

Abstract readSystematic ReviewMeta-Analysis
In one paragraph

Synthesis in Frontiers in immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Ruxandra Stefania DragotaDoctoral School, University of Medicine and Pharmacy of Craiova, Craiova, Romania.
Michael SchenkerOncology Department, Sf. Nectarie Oncology Center, Craiova, Romania.
Ana-Maria CiureaOncology Department, Sf. Nectarie Oncology Center, Craiova, Romania.
Adina Turcu-StiolicaBiostatistics Department, University of Medicine and Pharmacy Craiova, Craiova, Romania.
Mihaela PopescuDepartment of Endocrinology, University of Medicine and Pharmacy of Craiova, Craiova, Romania.
Andreea StanculescuDepartment of Anesthesiology and Intensive Care, Faculty of Medicine, University of Medicine and Pharmacy of Craiova, Craiova, Romania.
Bogdan Silviu UngureanuOncology Department, Sf. Nectarie Oncology Center, Craiova, Romania.
Tudorel CiureaGastroenterology Department, University of Medicine and Pharmacy of Craiova, Craiova, Romania.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: The Systemic Immune-Inflammation Index (SII), a composite biomarker integrating neutrophil, platelet, and lymphocyte counts, has been increasingly investigated in thyroid cancer. However, its diagnostic accuracy and association with lymph node metastasis (LNM) remain uncertain. This study aimed to systematically evaluate the diagnostic performance of SII for thyroid cancer and its association with LNM. Methods: A systematic literature search was conducted across PubMed, Scopus, and Web of Science. A diagnostic meta-analysis using the bivariate Reitsma model was performed to pool sensitivity, specificity, likelihood ratios, and the area under the summary receiver operating characteristic curve (AUC). The association between SII and LNM was assessed by pooling mean differences (MD) using an inverse-variance random-effects model. Heterogeneity was evaluated using I² statistics and Cochran's Q test. This systematic review was registered in PROSPERO (PROSPERO 2025 CRD420251233710). Results: Ten studies were included. The diagnostic meta-analysis (6 studies; 2,209 participants) yielded a pooled sensitivity of 76.8% (95% CI: 63.8-86.1%), specificity of 71.2% (95% CI: 54.9-83.4%), and AUC of 0.805. The positive and negative likelihood ratios were 2.78 and 0.34, respectively. The LNM meta-analysis (5 studies; 2,073 participants) demonstrated significantly higher SII in patients with LNM (MD = 102.87; 95% CI: 58.86-146.89; p < 0.00001; I² = 56%). Leave-one-out sensitivity analyses confirmed the robustness of both findings. Sensitivity analysis excluding one outlier study yielded consistent results with reduced heterogeneity (MD = 105.72; I² = 32%). Conclusion: SII demonstrates moderate diagnostic accuracy for thyroid cancer and is significantly elevated in patients with lymph node metastasis, supporting its potential as an adjunctive biomarker for diagnostic triage and preoperative risk stratification. Given substantial between-study heterogeneity, threshold variability, and partial verification bias affecting specificity, the pooled diagnostic estimates should be interpreted as preliminary and require confirmation in prospective studies with standardized cut-offs and uniform histopathological reference standards. Further large-scale prospective studies are warranted. Systematic review registration: https://www.crd.york.ac.uk/prospero/, identifier CRD420251233710.

Indexed as

InflammationLymphatic MetastasisThyroid NeoplasmsHumansSensitivity and SpecificitydiagnosticLNMSIIsystemic immune-inflammation indexthyroid cancer

Identifiers

PMID42433361
PMCPMC13350187

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.